Literature DB >> 9098616

Surgery in the treatment of multidrug-resistant tuberculosis.

M Pomerantz1, J M Brown.   

Abstract

Resectional surgery is recommended for patients with localized multidrug-resistant tuberculosis if adequate pulmonary reserve is present. Appropriate drug specific therapy is employed for approximately 3 months preoperatively and for 18 to 24 months postoperatively. Nutrition is emphasized both pre- and postoperatively. Technically, the use of bronchoscopy, double lumen endotracheal tubes, and muscle or omental flaps is stressed. With the above, cure rates should be better than 90%.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098616     DOI: 10.1016/s0272-5231(05)70361-0

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  6 in total

1.  Surgical management of multidrug-resistant tuberculosis.

Authors:  S Sasano; H Yamamoto; T Otsuka; A Fujita; T Onuki; S Nitta
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-02

Review 2.  Risk-benefit assessment of therapies for Mycobacterium avium complex infections.

Authors:  D E Griffith
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

Review 3.  Resurgence of therapeutically destitute tuberculosis: amalgamation of old and newer techniques.

Authors:  Ravindra Kumar Dewan; Loven Moodley
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

Review 4.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

5.  Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru.

Authors:  Jose G Somocurcio; Alfredo Sotomayor; Sonya Shin; Silvia Portilla; Maria Valcarcel; Dalia Guerra; Jennifer Furin
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

Review 6.  Extensively Drug-Resistant Tuberculosis: Report and Literature Review on Two Cases Requiring Prolonged Treatment.

Authors:  Martha Matos-Tocasca; Gabriel De la Cruz-Ku; Erick Auccacusi; Diego Fernandez-Salas; Tatiana García-Ahuanari; Bryan Valcarcel-Valdivia
Journal:  Am J Case Rep       Date:  2016-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.